ThinkEquity’s Woodburn Rates Verenium (Nasdaq:VRNM) at BUY – $3 Price Target
Source: http://feedproxy.google.com/~r/smallcappulse/feed/~3/EnOzWOqw-Go/Posted on Thursday, May 14th, 2009 | In Market Commentary, Small & Micro Cap
May 13, 2009 ndash; Analyst Comments ndash; ThinkEquityrsquo;s David Woodburn commented on Verenium (Nasdaq:VRNM) this morning, rating the stock at BUY with a price target of $3 (the stock closed at $0.61 yesterday). He cited improving enzyme profitability. Verenium reported Q1 financial results on Monday.
Financial Results
Verenium reported Q1 revenues of $14.4 million, compared with $15.2 million for the same period last year and a net loss of $0.3 million, compared with a $23.1 million net loss last year.
Woodburnrsquo;s Takeaways
middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Improved profitability in Specialty Enzyme business
middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; British Petroleumrsquo;s upfront cash contributions serve as validation of Vereniumrsquo;s technology and commercial prospects
middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; New government incentives should facilitates scale-up to commercial levels
middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Product gross margin of 45.5%
middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Reconfigured revenue and gross margin forecasts to account for Danisco agreement as well as boosts to production utilization and yield. FY09 revenue forecast declines to $65Mnbsp; from $90M but product GM is increased to 45.5% from 32%. FY09 EPS increases slightly to ($0.69).
middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Price target of $3 based on net present value calculation of enzyme business at value of about $2.14 per share and applying a group EP/revenue multiple of potential ldquo;ownedrdquo; cellulosic ethanol revenues that results in about $0.53 per share.
middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Rates at BUY nbsp;
Last 5 posts by Small Cap Pulse
- Global Hunter’s Justin Cable Maintains Neutral on Ormat (NYSE:ORA) - $45 Price Target - November 6th, 2009
- Global Hunter’s Justin Cable Maintains Neutral on Ormat (NYSE:ORA) - $45 Price Target - November 6th, 2009
- Pacific Crest’s Bachman Downgrades Evergreen Solar (Nasdaq:ESLR) to SECTOR PERFORM - November 6th, 2009
- Bachman Comments on Implications of First Solar (Nasdaq:FSLR) Land Purchase From Ausra - November 6th, 2009
- Cowen’s Stone Weighs in on Evergreen Solar (Nasdaq:ESLR) Q3 Results - November 5th, 2009
David Woodburn;, Market Commentary, New government;, Small & Micro Cap, small cap pulse, ThinkEquity's Woodburn Rates Verenium;, USD, Verenium;, Vereniumrsquo;s technology;
![]() About Small Cap Pulse (http://www.smallcappulse.com/index.php/blog/detail/)
Our focus at Small Cap Pulse is to provide our readers with timely and insightful stock ideas and market information, commentary about the economy and political conditions influencing it. We don't believe that stocks trade in a vacuum, so we believe that it is important to consider macroeconomics, the political climate, seculrar and industry trends that are relevant and necessary to consider when contemplating taking a long or short position, regardless of whether it is a long-term minded investment or a day-trade. So we will spend time discussing general conditions that we believe will influence the performance of companies that we report on in the Small Cap Pulse. We hope that you find our site informative and useful. |



